Last reviewed · How we verify

Unity Health Toronto — Portfolio Competitive Intelligence Brief

Unity Health Toronto pipeline: 12 marketed, 0 filed, 1 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

12 marketed 0 filed 1 Phase 3 5 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
furosemide administration furosemide administration marketed Loop diuretic Na-K-2Cl cotransporter (NKCC2) Cardiovascular
Zoloft (antidepressant) Zoloft (antidepressant) marketed Selective serotonin reuptake inhibitor (SSRI) Serotonin transporter (SERT) Psychiatry / Neurology
Whole Blood Whole Blood marketed
Semaglutide Pen Semaglutide Pen marketed
Oxygen + Midazolam Oxygen + Midazolam marketed Supportive care combination (oxygen + benzodiazepine) GABA-A receptor (midazolam component) Anesthesia/Procedural Sedation
Nitrous Oxide 99 % Nitrous Oxide 99 % marketed Inhalational anesthetic NMDA receptor Anesthesia
Meropenem Infusion Meropenem Infusion marketed Carbapenem antibiotic Penicillin-binding proteins (PBPs) Infectious Disease
Withdrawal of furosemide Withdrawal of furosemide marketed Cardiovascular
Saliva collection Saliva collection marketed
Rectal Methadone administer during spinal surgery Rectal Methadone administer during spinal surgery marketed
Nitrous oxide gas for inhalation Nitrous oxide gas for inhalation marketed Dissociative anesthetic NMDA receptor Anesthesia and Acute Pain Management
Topical timolol maleate Topical timolol maleate marketed Beta-adrenergic antagonist Beta-1 and beta-2 adrenergic receptors Ophthalmology

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Assistance Publique - Hôpitaux de Paris · 3 shared drug classes
  2. University of Florida · 2 shared drug classes
  3. Policlinico Casilino ASL RMB · 2 shared drug classes
  4. Second Affiliated Hospital, School of Medicine, Zhejiang University · 2 shared drug classes
  5. Sunnybrook Health Sciences Centre · 2 shared drug classes
  6. Bayer · 1 shared drug class
  7. B&A Therapeutics · 1 shared drug class
  8. Aspirus Heart and Vascular Institute-Research and Education · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Unity Health Toronto:

Cite this brief

Drug Landscape (2026). Unity Health Toronto — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/unity-health-toronto. Accessed 2026-05-16.

Related